• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter by Bernstein et al regarding article, "reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects.

作者信息

Bernstein Richard A, Alberts Mark J, Garcia David A

出版信息

Circulation. 2012 Apr 24;125(16):e614; author reply e616. doi: 10.1161/CIRCULATIONAHA.111.073668.

DOI:10.1161/CIRCULATIONAHA.111.073668
PMID:22529072
Abstract
摘要

相似文献

1
Letter by Bernstein et al regarding article, "reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects.伯恩斯坦等人就“凝血酶原复合物浓缩剂逆转利伐沙班和达比加群的作用：一项在健康受试者中进行的随机、安慰剂对照、交叉研究”一文所写的信。
Circulation. 2012 Apr 24;125(16):e614; author reply e616. doi: 10.1161/CIRCULATIONAHA.111.073668.
2
Letter by Marlu et al regarding article, "reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects".马鲁等人就“凝血酶原复合物浓缩剂逆转利伐沙班和达比加群的作用：一项在健康受试者中进行的随机、安慰剂对照、交叉研究”一文所写的信。
Circulation. 2012 Apr 24;125(16):e615; author reply e616. doi: 10.1161/CIRCULATIONAHA.111.073122.
3
Reversal of new oral anticoagulants.新型口服抗凝药的逆转
Circulation. 2011 Oct 4;124(14):1508-10. doi: 10.1161/CIRCULATIONAHA.111.054510.
4
Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects.在健康受试者中，用凝血酶原复合物浓缩物逆转利伐沙班和达比加群：一项随机、安慰剂对照、交叉研究。
Circulation. 2011 Oct 4;124(14):1573-9. doi: 10.1161/CIRCULATIONAHA.111.029017. Epub 2011 Sep 6.
5
Lack of an antagonist to reverse the action of dabigatran.缺乏可逆转达比加群作用的拮抗剂。
QJM. 2012 Feb;105(2):212-4. doi: 10.1093/qjmed/hcr214. Epub 2011 Nov 3.
6
Emergency surgery and trauma in patients treated with the new oral anticoagulants: dabigatran, rivaroxaban, and apixaban.接受新型口服抗凝剂（达比加群、利伐沙班和阿哌沙班）治疗的患者的急诊手术与创伤
J Trauma Acute Care Surg. 2014 Sep;77(3):486-94; quiz 486-94. doi: 10.1097/TA.0000000000000360.
7
Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro.凝血酶原复合物浓缩剂、活化凝血酶原复合物浓缩剂及重组活化因子VII在体外逆转利伐沙班诱导的抗凝作用。
Thromb Res. 2014 Apr;133(4):671-81. doi: 10.1016/j.thromres.2014.01.017. Epub 2014 Jan 21.
8
Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers.非特异性逆转剂对达比加群和利伐沙班抗凝活性的影响：健康志愿者中随机交叉的离体研究。
Thromb Haemost. 2012 Aug;108(2):217-24. doi: 10.1160/TH12-03-0179. Epub 2012 May 25.
9
In vitro assessment, using thrombin generation, of the applicability of prothrombin complex concentrate as an antidote for Rivaroxaban.使用凝血酶生成试验对凝血酶原复合物浓缩物作为利伐沙班解毒剂的适用性进行体外评估。
J Thromb Haemost. 2013 Jun;11(6):1111-8. doi: 10.1111/jth.12236.
10
Bleeding and antidotes in new oral anticoagulants.新型口服抗凝药物的出血与解毒。
Best Pract Res Clin Haematol. 2013 Jun;26(2):191-202. doi: 10.1016/j.beha.2013.07.001. Epub 2013 Jul 21.

引用本文的文献

1
Beyond warfarin: The advent of new oral anticoagulants.超越华法林：新型口服抗凝剂的问世。
Indian J Radiol Imaging. 2015 Oct-Dec;25(4):375-9. doi: 10.4103/0971-3026.169459.
2
Novel Anticoagulants in Atrial Fibrillation: Monitoring, Reversal and Perioperative Management.心房颤动中的新型抗凝剂：监测、逆转及围手术期管理
Biomed Res Int. 2015;2015:424031. doi: 10.1155/2015/424031. Epub 2015 Jul 2.